HPLC Analytical Method Development Validation
HPLC Analytical Method Development Validation
Scientists working with HPLC who need to further their understanding of the technique in
order to develop better methods faster. Scientists who have to validate HPLC methods in
accordance with current internationally-accepted guidance. HPLC technicians working in
R&D laboratories, quality control laboratories and stability testing laboratories.
Managers with a responsibility for generating regulatory submissions.
Speaker:
Dr Roland Collicott, as an exp erienc ed c onsultant and trainer, pro vides assistance to
the pharmaceutical industry in the areas of chiral analysis , polymorphic characterisation,
stability studies, chemical analysis in a GMP environment, specifications and all aspects of
international CMC documentation. He also runs training courses to cover many areas of
analytical chemistry, particularly in chromatography, chiral and polymorphic analysis. He has
served as an expert witness and consulted in trials in Canada, UK, South Africa and Germany.
Before becoming a consultant Roland was analytical section manager at OSI Pharmaceuticals
responsible for delivering validated analytical chemistry methods and CMC documentation for
OSIs regulatory submissions. In this role, he was responsible for collating and interpreting
data from a wide range of analytical techniques, acquired in-house or at contract, for the
characterisation of new compounds. There he also gained valuable international experience,
working closely with regulatory and clinical groups as well as manufacturing and analytical
contractors in Asia, Europe and the US.
Roland began his career in physical chemistry at Glaxo Group Research and originally
specialised in chromatography, introducing the use of chiral HPLC columns to resolve
enantiomers. He gained a PhD from his research into novel silicon-based chiral derivatisation
reagents for HPLC, GC and NMR analysis. In 1998 he joined British Biotech, where he became
involved in many other areas of analytical chemistry including polymorphism in pharmaceutical
products. As Group Leader, he managed British Biotech's QC procedures, stability testing and
the analytical development of its NCEs.
www.pharma-training-courses.com
Day Two
Acceptance criteria
Venues:
Amsterdam: Hotel Amsterdam, Damrak 93-94, Amsterdam 1012LP, Netherlands
Phone:+31(0)20 555 06 66
Website: www.hotelamsterdam.nl
London: DoubleTree Hilton, (formerly Jurys Inn) 60 Pentonville Road, Islington
London N1 9LA
Website: www.doubletree3.hilton.com
Accommodation and travel directions are available on our website
www.pharma-training-courses.com
For 5 or more staff requiring training it may be beneficial to run a course in-house.
The benefits of running a cou rse in -house:
Save on travel or accommodation costs
Customised content to meet your requirements
Big print savings on course material - especially with larger groups
Courses arranged for large groups up to 24 staff
Tutorials available for small groups of 2 or 3 staff
Meet course speakers in advance to discuss design and content
Contact Judy Callanan at any time to discuss
Ph: 0044 (0)20 7193 7703, Email: judy@pharma-training-courses.com
PharmaCourses Ltd
Suite 1327 Kemp House
152 City Road
London
UK
Tel: ++44 (0)20 71937703
Email: info@pharma-training-courses.com
REGISTRATION DETAILS:
UK: Under UK law all UK-based applications are subject to VAT at the prevailing rate however most UK VAT
registered companies/organisations can reclaim this tax.
EU: With effect from 1 January 2011 applications from delegates whose companies are based in EU countries will not
be subject to VAT PROVIDED THAT valid VAT ID details are provided at the time of booking, otherwise VAT will
be charged.
OTHER: With effect from 1 January 2011 applications from delegates whose companies are based outside of the UK/
EU will be outside the scope of VAT, ie no VAT is charged or payable.
www.pharma-training-courses.com